Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...

Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...

The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...

The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...

The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.

The system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.

Heart disease refers to any problem affecting the ... This occurs when the mitral valve in the heart does not close tightly enough, allowing blood to flow back into the heart.

It was well recognized that the mitral valve was the valve most commonly affected in rheumatic heart disease. As a consequence, closed-chest mitral commissurotomy for mitral stenosis (MS) was the most ...

Pacific Specialist Healthcare (PSH Hospitals) is taking a significant step forward in heart care with Rheumatic Heart Disease ...

Patients with thyrotoxicosis who developed thyroid storm died at nearly double the rate as those without thyroid storm, ...

However if you don’t have a congenital heart defect, there are some steps you can take to reduce the risk of developing aortic valve disease. Take antibiotics when you have strep throat to prevent ...

Introduction: Rheumatic heart disease remains a public health problem, especially in developing countries. The mitral valve (MV) is the main affected cardiac structure, requiring intervention in many ...